MLM Produced Data Featured in Harvard Publication for NEJM Evidence

MEMPHIS, TN; The interim analyses from REVERSE-IT (Rapid and Sustained Reversal of Ticagrelor – Intervention Trial) presented by Dr. Deepak L. Bhatt, MD, MPH at the American Heart Association  2021 Scientific Sessions, has now been published in NEJM Evidence. Our CSO, Dr. Lisa K. Jennings, and Lab Director, Dr. Ben Curry, PhD, are co-authors for this exciting publication.

MLM Medical Labs acts as the platelet core lab for this ongoing multicenter, single-arm, open-label trial to evaluate the efficacy and safety of bentracimab in ticagrelor-treated patients requiring urgent surgery or other invasive procedures or who have major bleeding. We are honored to be a part of bringing this therapeutic to patients in need by providing scientific excellence and high-quality data at every turn.